Published On: Wed, Oct 19th, 2016

Upgrades And Downgrades For Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH)


Recently stock market analysts have updated their consensus ratings on shares of Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH).

Most recent broker ratings

06/29/2015 – Kythera Biopharmaceuticals, Inc. was downgraded to “market perform” by analysts at Leerink Swann. They now have a USD 65 price target on the stock.

06/09/2015 – Guggenheim began new coverage on Kythera Biopharmaceuticals, Inc. giving the company a “buy” rating. They now have a USD 64 price target on the stock.

04/10/2015 – Bank of America Merrill Lynch began new coverage on Kythera Biopharmaceuticals, Inc. giving the company a “buy” rating. They now have a USD 66 price target on the stock.

11/11/2014 – Kythera Biopharmaceuticals, Inc. had its “outperform” rating reiterated by analysts at FBR Capital Markets. They now have a USD 59 price target on the stock.

Kythera Biopharmaceuticals, Inc. has a 50 day moving average of 74.78 and a 200 day moving average of 62.97.It has a 52-week low of 29.86 and a 52-week high of 76.31.

The share price of the company (NASDAQ:KYTH) was up +0.00% during the last trading session, with a high of 0.00 and the volume of Kythera Biopharmaceuticals, Inc. shares traded was 0.